UiPath is expanding its partnership with Deloitte through the professional services company's new Agentic ERP offering.

UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...

UiPath’s PATH advantage in the current automation race lies in how effectively its platform converts AI innovation into consistent enterprise efficiency. The company is moving beyond traditional ...

UiPath (NYSE:PATH) executives used the company’s latest earnings call question-and-answer session to emphasize what they ...

Will collaborate with other member organizations to develop and expand open protocols, tooling, and best practices for agent-based AI systems NEW YORK--(BUSINESS WIRE)-- UiPath (PATH) (NYSE: PATH), a ...

Offerings for medical records summarization, claim denial prevention and resolution, and prior authorization streamline payer/provider collaboration and dramatically reduce processing and payment ...

UiPath (NYSE: PATH), a global leader in agentic automation, today announced it has been named a Leader in The Forrester Wave(TM): Autonomous Testing Platforms, Q4 2025, reinforcing the company's ...

Artificial intelligence (AI) is changing the world we live in, and the next big change is coming in the form of AI agents.

After falling by over 80% from its previous peak, UiPath (NYSE: PATH) stock trades at a more favorable valuation that makes it a compelling buy for investors. The agentic AI specialist still trades at ...

UiPath closes fiscal year 2026 on a high, with co-Founder and CEO Daniel Dines making a bold case that falling AI development costs are good for the automation market, not a threat to it.